Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Hydrocortisone-cypionate | hsa00030 | Pentose phosphate pathway | 8.97E-03 | 1 | P11413 | G6PD | More | | Hydrocortisone-cypionate | hsa00190 | Oxidative phosphorylation | 4.09E-04 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Hydrocortisone-cypionate | hsa00220 | Arginine biosynthesis | 3.71E-06 | 3 | P15104, P05089, P49448 | GLUL, ARG1, GLUD2 | More | | Hydrocortisone-cypionate | hsa00250 | Alanine, aspartate and glutamate metabolism | 2.97E-03 | 2 | P49448, P15104 | GLUD2, GLUL | More | | Hydrocortisone-cypionate | hsa00280 | Valine, leucine and isoleucine degradation | 1.67E-02 | 4 | P55809, Q9HCC0, Q02252, P11310 | OXCT1, MCCC2, ALDH6A1, ACADM | More | | Hydrocortisone-cypionate | hsa00480 | Glutathione metabolism | 2.60E-05 | 5 | Q9UJ14, P11413, Q16772, P09211, P30041 | GGTL3, G6PD, GSTA3, GSTP1, PRDX6 | More | | Hydrocortisone-cypionate | hsa00500 | Starch and sucrose metabolism | 1.18E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Hydrocortisone-cypionate | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Hydrocortisone-cypionate | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 1.91E-02 | 1 | Q9NY97 | B3GNT2 | More | | Hydrocortisone-cypionate | hsa00561 | Glycerolipid metabolism | 2.21E-02 | 3 | O14494, P06280, P23743 | PLPP1, GLA, DGKA | More | | Hydrocortisone-cypionate | hsa00562 | Inositol phosphate metabolism | 3.69E-02 | 3 | P27987, P19174, P42338 | ITPKB, PLCG1, PIK3CB | More | | Hydrocortisone-cypionate | hsa00600 | Sphingolipid metabolism | 3.96E-02 | 3 | Q9BX95, O14494, P06280 | SGPP1, PLPP1, GLA | More | | Hydrocortisone-cypionate | hsa00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 3.78E-02 | 1 | Q9NY97 | B3GNT2 | More | | Hydrocortisone-cypionate | hsa00730 | Thiamine metabolism | 4.32E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Hydrocortisone-cypionate | hsa00910 | Nitrogen metabolism | 2.97E-03 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Hydrocortisone-cypionate | hsa00970 | Aminoacyl-tRNA biosynthesis | 1.94E-03 | 3 | O95363, P14868, Q15046 | FARS2, DARS, KARS | More | | Hydrocortisone-cypionate | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Hydrocortisone-cypionate | hsa00982 | Drug metabolism - cytochrome P450 | 1.06E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Hydrocortisone-cypionate | hsa00983 | Drug metabolism - other enzymes | 1.72E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Hydrocortisone-cypionate | hsa01100 | Metabolic pathways | 8.43E-03 | 11 | P35790, Q16772, P09211, Q9UJ14, P30041, P40926, Q7KZN9, P15121, Q9UHK6, Q86VZ5, Q9BQB6 | CHKA, GSTA3, GSTP1, GGTL3, PRDX6, MDH2, COX15, AKR1B1, AMACR, SGMS1, VKORC1 | More | | Hydrocortisone-cypionate | hsa01200 | Carbon metabolism | 2.91E-02 | 1 | P11413 | G6PD | More | | Hydrocortisone-cypionate | hsa01210 | 2-Oxocarboxylic acid metabolism | 6.96E-04 | 1 | P50213 | IDH3A | More | | Hydrocortisone-cypionate | hsa01524 | Platinum drug resistance | 4.44E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Hydrocortisone-cypionate | hsa03013 | RNA transport | 9.39E-05 | 9 | Q15287, Q9UBU9, P35658, P63279, P68104, P55884, O15371, P20042, Q14232 | RNPS1, NXF1, NUP214, UBE2I, EEF1A1, EIF3B, EIF3D, EIF2S2, EIF2B1 | More | | Hydrocortisone-cypionate | hsa03040 | Spliceosome | 1.81E-06 | 16 | O43143, O60508, P08579, Q15427, P26368, P38159, P61978, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX15, CDC40, SNRPB2, SF3B4, U2AF2, RBMX, HNRPK, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | | Hydrocortisone-cypionate | hsa03060 | Protein export | 9.07E-04 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Hydrocortisone-cypionate | hsa04012 | ErbB signaling pathway | 3.57E-03 | 6 | P21860, Q13191, Q13557, P19174, O14944, P42338 | ERBB3, CBLB, CAMK2D, PLCG1, EREG, PIK3CB | More | | Hydrocortisone-cypionate | hsa04014 | Ras signaling pathway | 2.36E-02 | 8 | P42338, P20827, P49767, Q13009, Q7LDG7, P63218, P50151, P19174 | PIK3CB, EFNA1, VEGFC, TIAM1, RASGRP2, GNG5, GNG10, PLCG1 | More | | Hydrocortisone-cypionate | hsa04015 | Rap1 signaling pathway | 1.79E-02 | 8 | P20827, P49767, Q96FS4, P11215, Q13009, Q7LDG7, P42338, P19174 | EFNA1, VEGFC, SIPA1, ITGAM, TIAM1, RASGRP2, PIK3CB, PLCG1 | More | | Hydrocortisone-cypionate | hsa04020 | Calcium signaling pathway | 2.19E-05 | 10 | Q96DU7, Q08828, P45880, Q13557, P21860, P61073, P0DP24, P05141, P51828, P23634 | ITPKC, ADCY1, VDAC2, CAMK2D, ERBB3, CXCR4, CALM2, SLC25A5, ADCY7, ATP2B4 | More | | Hydrocortisone-cypionate | hsa04022 | cGMP-PKG signaling pathway | 2.45E-03 | 8 | Q99941, P18848, P23634, Q08828, P51828, P05141, P45880, P0DP24 | CREBL1, ATF4, ATP2B4, ADCY1, ADCY7, SLC25A5, VDAC2, CALM2 | More | | Hydrocortisone-cypionate | hsa04060 | Cytokine-cytokine receptor interaction | 2.09E-02 | 8 | P14784, P14778, Q06643, Q13651, Q9HBE5, P09341, P19875, Q93038 | IL2RB, IL1R1, LTB, IL10RA, IL21R, CXCL1, CXCL2, TNFRSF25 | More | | Hydrocortisone-cypionate | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 9.15E-04 | 9 | Q8NHW4, P09341, P25024, P25025, P61073, P47992, Q9UBD3, Q13651, P01375 | CCL4L2, CXCL1, CXCR1, CXCR2, CXCR4, XCL1, XCL2, IL10RA, TNF | More | | Hydrocortisone-cypionate | hsa04062 | Chemokine signaling pathway | 3.82E-05 | 15 | P25024, P25025, P09769, P07948, P42338, P19174, P63218, P50151, P43250, P49407, Q08881, Q7LDG7, Q13009, P49841, Q8WYR1 | CXCR1, CXCR2, FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, ARRB1, ITK, RASGRP2, TIAM1, GSK3B, PIK3R5 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P60033 | CD81 | CD81 antigen | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | -0.873 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | 0.909 | P60033 | CD81 | CD81 antigen | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | -0.76 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.86 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P09769 | FGR | Tyrosine-protein kinase Fgr | 0.796 | P60033 | CD81 | CD81 antigen | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.884 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.971 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.795 | P60033 | CD81 | CD81 antigen | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.714 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.751 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P60033 | CD81 | CD81 antigen | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.818 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.733 | P60033 | CD81 | CD81 antigen | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.884 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.875 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43250 | GRK6 | G protein-coupled receptor kinase 6 | 0.818 | P60033 | CD81 | CD81 antigen | P49407 | ARRB1 | Beta-arrestin-1 | 0.707 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P49407 | ARRB1 | Beta-arrestin-1 | -0.853 | P60033 | CD81 | CD81 antigen | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.726 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | 0.706 | P60033 | CD81 | CD81 antigen | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.808 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.812 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.752 |
| Hydrocortisone-cypionate | hsa04064 | NF-kappa B signaling pathway | 4.54E-05 | 17 | P10415, Q13489, P14778, P01584, P29965, P19174, Q04759, Q9UDY8, P06239, Q8WV28, Q13315, P63279, Q8NHW4, P09341, P19875, Q06643, Q9NQC7 | BCL2, BIRC3, IL1R1, IL1B, CD40LG, PLCG1, PRKCQ, MALT1, LCK, BLNK, ATM, UBE2I, CCL4L2, CXCL1, CXCL2, LTB, CYLD | More | | Hydrocortisone-cypionate | hsa04070 | Phosphatidylinositol signaling system | 3.47E-02 | 4 | P0DP23, Q14643, P23743, P17252 | CALM1, ITPR1, DGKA, PRKCA | More | | Hydrocortisone-cypionate | hsa04071 | Sphingolipid signaling pathway | 4.49E-02 | 4 | P17252, Q13362, Q9BX95, P10415 | PRKCA, PPP2R5C, SGPP1, BCL2 | More | | Hydrocortisone-cypionate | hsa04072 | Phospholipase D signaling pathway | 1.78E-02 | 6 | P42338, P43657, P25024, P25025, Q14344, Q9GZP0 | PIK3CB, P2RY5, CXCR1, CXCR2, GNA13, PDGFD | More | | Hydrocortisone-cypionate | hsa04114 | Oocyte meiosis | 4.36E-02 | 5 | Q13557, P0DP24, Q08828, P51828, P27348 | CAMK2D, CALM2, ADCY1, ADCY7, YWHAQ | More | | Hydrocortisone-cypionate | hsa04140 | Autophagy - animal | 1.76E-03 | 7 | Q9Y4H2, P42338, Q9NQL2, P22694, Q14643, Q9H1Y0, Q04759 | IRS2, PIK3CB, RRAGD, PRKACB, ITPR1, ATG5, PRKCQ | More | | Hydrocortisone-cypionate | hsa04141 | Protein processing in endoplasmic reticulum | 4.34E-04 | 10 | P07384, O95487, Q99941, O75460, P17861, P11142, Q9H3Z4, P07900, Q9NR31, O95816 | CAPN1, SEC24B, CREBL1, ERN1, XBP1, HSPA8, DNAJC5, HSP90AA1, SAR1A, BAG2 | More | | Hydrocortisone-cypionate | hsa04145 | Phagosome | 2.83E-04 | 9 | P60709, Q15075, Q15080, P14598, Q13509, P68371, Q13488, O60603, P13765 | ACTB, EEA1, NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, TLR2, HLA-DOB | More | | Hydrocortisone-cypionate | hsa04150 | mTOR signaling pathway | 2.72E-02 | 4 | P42338, Q9NQL2, Q13322, P49841 | PIK3CB, RRAGD, GRB10, GSK3B | More | | Hydrocortisone-cypionate | hsa04151 | PI3K-Akt signaling pathway | 5.33E-03 | 20 | P42338, P43657, P25116, P20827, P49767, Q13362, P08238, Q8WYR1, P62873, P63218, P50151, P16144, O15335, Q13751, O60603, P14784, P01568, P10415, P17252, P30281 | PIK3CB, P2RY5, F2R, EFNA1, VEGFC, PPP2R5C, HSP90AB1, PIK3R5, GNB1, GNG5, GNG10, ITGB4, CHAD, LAMB3, TLR2, IL2RB, IFNA21, BCL2, PRKCA, CCND3 | More | | Hydrocortisone-cypionate | hsa04211 | Longevity regulating pathway | 4.98E-02 | 4 | Q08828, P51828, Q99941, P18848 | ADCY1, ADCY7, CREBL1, ATF4 | More | | Hydrocortisone-cypionate | hsa04213 | Longevity regulating pathway - multiple species | 1.56E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Hydrocortisone-cypionate | hsa04217 | Necroptosis | 1.68E-04 | 14 | P01568, P23458, Q13489, Q9NQC7, P42224, P05141, P01584, P0C0S5, Q6FI13, P10415, Q13557, Q9H444, O43633, Q08752 | IFNA21, JAK1, BIRC3, CYLD, STAT1, SLC25A5, IL1B, H2AFZ, H2AC18; H2AC19, BCL2, CAMK2D, CHMP4B, CHMP2A, PPID | More | | Hydrocortisone-cypionate | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.49E-04 | 12 | P09493, Q08828, P51828, Q99941, P18848, Q13362, P0DP23, P0DP24, Q13557, P17252, P10415, P23634 | TPM1, ADCY1, ADCY7, CREBL1, ATF4, PPP2R5C, CALM1, CALM2, CAMK2D, PRKCA, BCL2, ATP2B4 | More | | Hydrocortisone-cypionate | hsa04330 | Notch signaling pathway | 4.34E-02 | 2 | Q92542, P46531 | NCSTN, NOTCH1 | More | | Hydrocortisone-cypionate | hsa04360 | Axon guidance | 2.74E-03 | 8 | P16333, P20827, O95631, P42338, P07332, P23528, P19174, Q06124 | NCK1, EFNA1, NTN1, PIK3CB, FES, CFL1, PLCG1, PTPN11 | More | | Hydrocortisone-cypionate | hsa04370 | VEGF signaling pathway | 4.05E-02 | 2 | P19174, P42338 | PLCG1, PIK3CB | More | | Hydrocortisone-cypionate | hsa04371 | Apelin signaling pathway | 1.00E-02 | 7 | P63218, P50151, Q8WYR1, Q14814, Q14344, Q13485, P84022 | GNG5, GNG10, PIK3R5, MEF2D, GNA13, SMAD4, SMAD3 | More | | Hydrocortisone-cypionate | hsa04380 | Osteoclast differentiation | 7.71E-05 | 13 | P09603, Q9NQC7, Q9UQC2, Q16539, P23458, P06239, P42338, P01584, P14778, O75015, P01375, Q8N149, P78324 | CSF1, CYLD, GAB2, MAPK14, JAK1, LCK, PIK3CB, IL1B, IL1R1, FCGR3B, TNF, LILRA2, SIRPA | More | | Hydrocortisone-cypionate | hsa04390 | Hippo signaling pathway | 4.35E-02 | 2 | P63261, O15105 | ACTG1, SMAD7 | More | | Hydrocortisone-cypionate | hsa04530 | Tight junction | 2.17E-03 | 3 | P63261, Q9Y478, Q92974 | ACTG1, PRKAB1, ARHGEF2 | More | | Hydrocortisone-cypionate | hsa04540 | Gap junction | 1.29E-02 | 4 | P17252, Q13509, P68371, Q14643 | PRKCA, TUBB3, TUBB2C, ITPR1 | More | | Hydrocortisone-cypionate | hsa04612 | Antigen processing and presentation | 1.77E-03 | 10 | P13765, P48382, P26715, P26717, Q07444, Q13241, P01732, P30101, P11142, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRC3, KLRD1, CD8A, PDIA3, HSPA8, TNF | More | | Hydrocortisone-cypionate | hsa04613 | Neutrophil extracellular trap formation | 2.29E-03 | 18 | P17252, O60603, P05164, P08246, Q9UM07, Q13547, Q6FI13, Q16778, P68431, P14598, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | PRKCA, TLR2, MPO, ELA2, PADI4, HDAC1, H2AC18; H2AC19, HIST2H2BE, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Hydrocortisone-cypionate | hsa04621 | NOD-like receptor signaling pathway | 1.85E-02 | 10 | Q16539, Q14643, P10599, Q9H1Y0, P43490, O00463, P29728, P01375, P09341, P12838 | MAPK14, ITPR1, TXN, ATG5, PBEF1, TRAF5, OAS2, TNF, CXCL1, DEFA4 | More | | Hydrocortisone-cypionate | hsa04623 | Cytosolic DNA-sensing pathway | 1.20E-02 | 2 | P01584, Q8NHW4 | IL1B, CCL4L2 | More | | Hydrocortisone-cypionate | hsa04625 | C-type lectin receptor signaling pathway | 3.04E-02 | 5 | Q9ULY5, P20749, P01375, Q13191, P42338 | CLEC4E, BCL3, TNF, CBLB, PIK3CB | More | | Hydrocortisone-cypionate | hsa04640 | Hematopoietic cell lineage | 5.34E-04 | 12 | P13612, P14778, P27930, P11215, P15144, P25063, P07766, P09693, P01732, P09564, P13765, P01375 | ITGA4, IL1R1, IL1R2, ITGAM, ANPEP, CD24, CD3E, CD3G, CD8A, CD7, HLA-DOB, TNF | More | | Hydrocortisone-cypionate | hsa04650 | Natural killer cell mediated cytotoxicity | 3.33E-07 | 13 | P19174, P01375, P06239, O60880, P20963, P42338, Q13241, P26718, O14931, O75015, P26717, Q07444, P26715 | PLCG1, TNF, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC3, KLRC1 | More | | Hydrocortisone-cypionate | hsa04657 | IL-17 signaling pathway | 1.42E-02 | 7 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF | More | | Hydrocortisone-cypionate | hsa04658 | Th1 and Th2 cell differentiation | 1.21E-09 | 14 | Q04759, P07766, P20963, P09693, Q16539, P19174, P01730, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, CD4, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Hydrocortisone-cypionate | hsa04659 | Th17 cell differentiation | 3.81E-09 | 17 | Q04759, Q16539, P19174, P01730, P06239, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, P84022, Q13485, P08238, P07766, P09693, P20963 | PRKCQ, MAPK14, PLCG1, CD4, LCK, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, SMAD3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P24723 | PRKCH | Protein kinase C eta type | Q04759 | PRKCQ | Protein kinase C theta type | 0.791 | P12429 | ANXA3 | Annexin A3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.906 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.817 | P12429 | ANXA3 | Annexin A3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.805 | P24723 | PRKCH | Protein kinase C eta type | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.767 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.84 | P24723 | PRKCH | Protein kinase C eta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.912 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.825 | P12429 | ANXA3 | Annexin A3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.753 | P24723 | PRKCH | Protein kinase C eta type | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.876 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P12429 | ANXA3 | Annexin A3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.76 | P24723 | PRKCH | Protein kinase C eta type | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.705 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.764 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.936 | P12429 | ANXA3 | Annexin A3 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.749 | P24723 | PRKCH | Protein kinase C eta type | Q9HBE5 | IL21R | Interleukin-21 receptor | 0.776 | P24723 | PRKCH | Protein kinase C eta type | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.856 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.752 | P12429 | ANXA3 | Annexin A3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.858 | P12429 | ANXA3 | Annexin A3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.832 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P24723 | PRKCH | Protein kinase C eta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.887 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.838 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.852 | P12429 | ANXA3 | Annexin A3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.769 | P24723 | PRKCH | Protein kinase C eta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.939 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.775 | P12429 | ANXA3 | Annexin A3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.877 |
| Hydrocortisone-cypionate | hsa04660 | T cell receptor signaling pathway | 5.04E-09 | 15 | P01375, Q04759, P42338, O95267, Q08881, P19174, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, Q16539, P49841 | TNF, PRKCQ, PIK3CB, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, MAPK14, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P60033 | CD81 | CD81 antigen | P01375 | TNF | Tumor necrosis factor | -0.71 | P12429 | ANXA3 | Annexin A3 | P01375 | TNF | Tumor necrosis factor | 0.832 | P24723 | PRKCH | Protein kinase C eta type | Q04759 | PRKCQ | Protein kinase C theta type | 0.791 | P12429 | ANXA3 | Annexin A3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.906 | P24723 | PRKCH | Protein kinase C eta type | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.79 | P60033 | CD81 | CD81 antigen | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.714 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.751 | P12429 | ANXA3 | Annexin A3 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.77 | P60033 | CD81 | CD81 antigen | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.726 | P12429 | ANXA3 | Annexin A3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.836 | P24723 | PRKCH | Protein kinase C eta type | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.767 | P24723 | PRKCH | Protein kinase C eta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.887 | P60033 | CD81 | CD81 antigen | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.852 | P24723 | PRKCH | Protein kinase C eta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.939 | P60033 | CD81 | CD81 antigen | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.77 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.775 | P12429 | ANXA3 | Annexin A3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.877 | P12429 | ANXA3 | Annexin A3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.769 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.84 | P24723 | PRKCH | Protein kinase C eta type | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.838 | P12429 | ANXA3 | Annexin A3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.77 | P24723 | PRKCH | Protein kinase C eta type | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.779 | P60033 | CD81 | CD81 antigen | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.749 | P12429 | ANXA3 | Annexin A3 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.814 | P24723 | PRKCH | Protein kinase C eta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.912 | P60033 | CD81 | CD81 antigen | P06239 | LCK | Tyrosine-protein kinase Lck | 0.795 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.825 | P12429 | ANXA3 | Annexin A3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.753 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.817 | P12429 | ANXA3 | Annexin A3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.805 | P60033 | CD81 | CD81 antigen | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.808 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.812 | P12429 | ANXA3 | Annexin A3 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.743 |
| Hydrocortisone-cypionate | hsa04662 | B cell receptor signaling pathway | 4.96E-07 | 6 | P49841, P42338, P60033, P07948, P21854, Q8N149 | GSK3B, PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Hydrocortisone-cypionate | hsa04664 | Fc epsilon RI signaling pathway | 5.70E-05 | 6 | P01375, Q16539, P42338, P07948, P19174, P09917 | TNF, MAPK14, PIK3CB, LYN, PLCG1, ALOX5 | More | | Hydrocortisone-cypionate | hsa04668 | TNF signaling pathway | 4.74E-02 | 3 | Q99941, P01584, O95429 | CREBL1, IL1B, BAG4 | More | | Hydrocortisone-cypionate | hsa04672 | Intestinal immune network for IgA production | 3.76E-03 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Hydrocortisone-cypionate | hsa04713 | Circadian entrainment | 1.25E-03 | 8 | P0DP23, P0DP24, Q13557, P17252, P62873, Q14643, Q08828, P51828 | CALM1, CALM2, CAMK2D, PRKCA, GNB1, ITPR1, ADCY1, ADCY7 | More | | Hydrocortisone-cypionate | hsa04714 | Thermogenesis | 1.25E-02 | 3 | P15336, P63261, Q9Y478 | ATF2, ACTG1, PRKAB1 | More | | Hydrocortisone-cypionate | hsa04720 | Long-term potentiation | 1.63E-03 | 7 | P17252, Q13557, P0DP23, P0DP24, P18848, Q08828, Q14643 | PRKCA, CAMK2D, CALM1, CALM2, ATF4, ADCY1, ITPR1 | More | | Hydrocortisone-cypionate | hsa04722 | Neurotrophin signaling pathway | 9.39E-03 | 2 | Q05655, P52566 | PRKCD, ARHGDIB | More | | Hydrocortisone-cypionate | hsa04723 | Retrograde endocannabinoid signaling | 1.88E-03 | 8 | Q14643, P17252, P62873, P63218, P50151, P48058, Q16539, Q16718 | ITPR1, PRKCA, GNB1, GNG5, GNG10, GRIA4, MAPK14, NDUFA5 | More | | Hydrocortisone-cypionate | hsa04724 | Glutamatergic synapse | 7.09E-03 | 5 | P48058, P43003, P63218, P50151, P15104 | GRIA4, SLC1A3, GNG5, GNG10, GLUL | More | | Hydrocortisone-cypionate | hsa04725 | Cholinergic synapse | 1.75E-03 | 8 | Q08828, P51828, Q14643, P17252, P62873, P18848, Q13557, P10415 | ADCY1, ADCY7, ITPR1, PRKCA, GNB1, ATF4, CAMK2D, BCL2 | More | | Hydrocortisone-cypionate | hsa04728 | Dopaminergic synapse | 1.89E-04 | 16 | Q14643, P17252, P62873, P63218, P50151, P49841, Q99941, P18848, Q16539, Q13557, P49407, Q13362, P0DP23, P0DP24, O15516, P48058 | ITPR1, PRKCA, GNB1, GNG5, GNG10, GSK3B, CREBL1, ATF4, MAPK14, CAMK2D, ARRB1, PPP2R5C, CALM1, CALM2, CLOCK, GRIA4 | More | | Hydrocortisone-cypionate | hsa04744 | Phototransduction | 1.02E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Hydrocortisone-cypionate | hsa04750 | Inflammatory mediator regulation of TRP channels | 6.91E-07 | 13 | P14778, P01584, Q08828, P51828, P22694, Q13557, Q16539, P19174, P42338, Q14643, P24723, Q04759, P0DP24 | IL1R1, IL1B, ADCY1, ADCY7, PRKACB, CAMK2D, MAPK14, PLCG1, PIK3CB, ITPR1, PRKCH, PRKCQ, CALM2 | More | | Hydrocortisone-cypionate | hsa04911 | Insulin secretion | 2.95E-05 | 5 | Q08828, P51828, Q99941, P18848, Q13557 | ADCY1, ADCY7, CREBL1, ATF4, CAMK2D | More | | Hydrocortisone-cypionate | hsa04912 | GnRH signaling pathway | 5.97E-04 | 8 | P17252, Q08828, P51828, P18848, Q13557, Q14643, P0DP23, P0DP24 | PRKCA, ADCY1, ADCY7, ATF4, CAMK2D, ITPR1, CALM1, CALM2 | More | | Hydrocortisone-cypionate | hsa04915 | Estrogen signaling pathway | 4.72E-02 | 4 | Q99941, P51828, P07900, P11142 | CREBL1, ADCY7, HSP90AA1, HSPA8 | More | | Hydrocortisone-cypionate | hsa04916 | Melanogenesis | 7.61E-03 | 4 | Q13557, P0DP24, Q08828, P51828 | CAMK2D, CALM2, ADCY1, ADCY7 | More | | Hydrocortisone-cypionate | hsa04918 | Thyroid hormone synthesis | 4.47E-03 | 5 | Q08828, P51828, Q99941, P18848, P02768 | ADCY1, ADCY7, CREBL1, ATF4, ALB | More | | Hydrocortisone-cypionate | hsa04920 | Adipocytokine signaling pathway | 2.80E-02 | 2 | Q06124, Q9Y478 | PTPN11, PRKAB1 | More | | Hydrocortisone-cypionate | hsa04922 | Glucagon signaling pathway | 3.47E-02 | 4 | Q12778, Q13370, P0DP23, Q14643 | FOXO1, PDE3B, CALM1, ITPR1 | More | | Hydrocortisone-cypionate | hsa04924 | Renin secretion | 8.71E-03 | 3 | Q14643, Q13370, P0DP23 | ITPR1, PDE3B, CALM1 | More | | Hydrocortisone-cypionate | hsa04925 | Aldosterone synthesis and secretion | 8.00E-06 | 7 | Q99941, P18848, Q08828, P51828, P0DP24, Q13557, P23634 | CREBL1, ATF4, ADCY1, ADCY7, CALM2, CAMK2D, ATP2B4 | More | | Hydrocortisone-cypionate | hsa04927 | Cortisol synthesis and secretion | 4.16E-03 | 4 | Q99941, P18848, Q08828, P51828 | CREBL1, ATF4, ADCY1, ADCY7 | More | | Hydrocortisone-cypionate | hsa04928 | Parathyroid hormone synthesis, secretion and action | 3.77E-02 | 4 | Q08828, P51828, Q99941, P18848 | ADCY1, ADCY7, CREBL1, ATF4 | More | | Hydrocortisone-cypionate | hsa04930 | Type II diabetes mellitus | 2.68E-02 | 1 | Q05655 | PRKCD | More | | Hydrocortisone-cypionate | hsa04932 | Non-alcoholic fatty liver disease | 3.45E-02 | 5 | P18848, O75460, P01584, P12074, O15239 | ATF4, ERN1, IL1B, COX6A1, NDUFA1 | More | | Hydrocortisone-cypionate | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.19E-03 | 9 | P84022, Q13485, P42224, P10415, P42338, Q12778, P49767, P17252, P19174 | SMAD3, SMAD4, STAT1, BCL2, PIK3CB, FOXO1, VEGFC, PRKCA, PLCG1 | More | | Hydrocortisone-cypionate | hsa04934 | Cushing syndrome | 2.69E-06 | 6 | Q99941, P18848, Q08828, P51828, O15169, Q13557 | CREBL1, ATF4, ADCY1, ADCY7, AXIN1, CAMK2D | More | | Hydrocortisone-cypionate | hsa04935 | Growth hormone synthesis, secretion and action | 4.98E-02 | 4 | Q08828, P51828, Q99941, P18848 | ADCY1, ADCY7, CREBL1, ATF4 | More | | Hydrocortisone-cypionate | hsa04966 | Collecting duct acid secretion | 2.86E-02 | 2 | Q13488, Q9Y666 | TCIRG1, SLC12A7 | More | | Hydrocortisone-cypionate | hsa04970 | Salivary secretion | 3.54E-02 | 3 | Q08828, P51828, P0DP24 | ADCY1, ADCY7, CALM2 | More | | Hydrocortisone-cypionate | hsa04971 | Gastric acid secretion | 2.95E-05 | 5 | Q08828, P51828, P15311, P0DP24, Q13557 | ADCY1, ADCY7, VIL2, CALM2, CAMK2D | More | | Hydrocortisone-cypionate | hsa04973 | Carbohydrate digestion and absorption | 2.44E-04 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Hydrocortisone-cypionate | hsa05010 | Alzheimer disease | 2.50E-06 | 32 | Q92542, P01375, O15239, Q16718, O14521, P05496, Q06055, P12074, Q14643, Q00535, Q9NZJ5, O75460, P0DP23, P0DP24, Q13564, P49841, P01584, P18848, Q13509, P68371, O15169, Q92837, P09603, P42338, P05141, P21796, P45880, Q08752, P17861, P28070, P43686, P62195 | NCSTN, TNF, NDUFA1, NDUFA5, SDHD, ATP5G1, ATP5G2, COX6A1, ITPR1, CDK5, EIF2AK3, ERN1, CALM1, CALM2, APPBP1, GSK3B, IL1B, ATF4, TUBB3, TUBB2C, AXIN1, FRAT1, CSF1, PIK3CB, SLC25A5, VDAC1, VDAC2, PPID, XBP1, PSMB4, PSMC4, PSMC5 | More | | Hydrocortisone-cypionate | hsa05012 | Parkinson disease | 9.44E-05 | 18 | O15239, Q16718, O14521, P12074, Q06055, P05141, O75460, P18848, P17861, P28070, P43686, P62195, Q14643, P0DP23, P0DP24, Q13557, Q13509, P68371 | NDUFA1, NDUFA5, SDHD, COX6A1, ATP5G2, SLC25A5, ERN1, ATF4, XBP1, PSMB4, PSMC4, PSMC5, ITPR1, CALM1, CALM2, CAMK2D, TUBB3, TUBB2C | More | | Hydrocortisone-cypionate | hsa05014 | Amyotrophic lateral sclerosis | 1.01E-02 | 3 | Q06055, P17861, P62195 | ATP5G2, XBP1, PSMC5 | More | | Hydrocortisone-cypionate | hsa05016 | Huntington disease | 3.54E-02 | 8 | O15239, P12074, P24928, P62487, P05141, O75460, P28070, P43686 | NDUFA1, COX6A1, POLR2A, POLR2G, SLC25A5, ERN1, PSMB4, PSMC4 | More | | Hydrocortisone-cypionate | hsa05017 | Spinocerebellar ataxia | 1.42E-02 | 2 | P17861, P62195 | XBP1, PSMC5 | More | | Hydrocortisone-cypionate | hsa05020 | Prion disease | 9.80E-05 | 19 | P01584, P46531, P11142, O15239, Q16718, O14521, P05496, P12074, Q14643, P18848, P05141, P45880, P28070, P43686, Q13509, P68371, Q99941, P14598, Q15080 | IL1B, NOTCH1, HSPA8, NDUFA1, NDUFA5, SDHD, ATP5G1, COX6A1, ITPR1, ATF4, SLC25A5, VDAC2, PSMB4, PSMC4, TUBB3, TUBB2C, CREBL1, NCF1, NCF4 | More | | Hydrocortisone-cypionate | hsa05022 | Pathways of neurodegeneration - multiple diseases | 8.91E-06 | 26 | Q14643, Q13509, P68371, P10415, O15239, Q16718, O14521, P12074, Q06055, Q8TEV9, O75460, P18848, P17861, Q13561, P05141, P17252, Q00535, O15169, P01584, Q08752, P0DP23, P0DP24, Q13557, P28070, P43686, P62195 | ITPR1, TUBB3, TUBB2C, BCL2, NDUFA1, NDUFA5, SDHD, COX6A1, ATP5G2, SMCR8, ERN1, ATF4, XBP1, DCTN2, SLC25A5, PRKCA, CDK5, AXIN1, IL1B, PPID, CALM1, CALM2, CAMK2D, PSMB4, PSMC4, PSMC5 | More | | Hydrocortisone-cypionate | hsa05030 | Cocaine addiction | 3.54E-02 | 3 | Q00535, Q99941, P18848 | CDK5, CREBL1, ATF4 | More | | Hydrocortisone-cypionate | hsa05031 | Amphetamine addiction | 7.61E-03 | 4 | P0DP24, Q13557, Q99941, P18848 | CALM2, CAMK2D, CREBL1, ATF4 | More | | Hydrocortisone-cypionate | hsa05110 | Vibrio cholerae infection | 4.50E-03 | 4 | Q13488, P17252, P19174, P60709 | TCIRG1, PRKCA, PLCG1, ACTB | More | | Hydrocortisone-cypionate | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 3.24E-03 | 7 | Q16539, P09341, P19875, P19174, P25024, P25025, P07948 | MAPK14, CXCL1, CXCL2, PLCG1, CXCR1, CXCR2, LYN | More | | Hydrocortisone-cypionate | hsa05130 | Pathogenic Escherichia coli infection | 9.80E-03 | 4 | Q92974, P63261, Q06124, O95487 | ARHGEF2, ACTG1, PTPN11, SEC24B | More | | Hydrocortisone-cypionate | hsa05131 | Shigellosis | 3.99E-03 | 10 | P68431, Q05655, Q9UDY8, Q14247, Q14643, Q12778, Q13315, P10415, Q08752, P07737 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, PRKCD, MALT1, CTTN, ITPR1, FOXO1, ATM, BCL2, PPID, PFN1 | More | | Hydrocortisone-cypionate | hsa05132 | Salmonella infection | 6.68E-03 | 10 | Q9UJU2, P84095, Q13489, P10415, P07737, O60603, Q9BQS8, Q13561, Q13509, P68371 | LEF1, RHOG, BIRC3, BCL2, PFN1, TLR2, FYCO1, DCTN2, TUBB3, TUBB2C | More | | Hydrocortisone-cypionate | hsa05134 | Legionellosis | 2.92E-04 | 6 | Q9NR31, P11215, P68104, P11142, P09341, P19875 | SAR1A, ITGAM, EEF1A1, HSPA8, CXCL1, CXCL2 | More | | Hydrocortisone-cypionate | hsa05135 | Yersinia infection | 1.92E-05 | 9 | P13612, P06239, P19174, Q16539, P01375, P42338, P49841, P01730, P01732 | ITGA4, LCK, PLCG1, MAPK14, TNF, PIK3CB, GSK3B, CD4, CD8A | More | | Hydrocortisone-cypionate | hsa05140 | Leishmaniasis | 3.96E-05 | 11 | P13612, O75015, P14598, P42224, P13765, O60603, P25963, P01375, P29350, Q16539, Q15080 | ITGA4, FCGR3B, NCF1, STAT1, HLA-DOB, TLR2, NFKBIA, TNF, PTPN6, MAPK14, NCF4 | More | | Hydrocortisone-cypionate | hsa05144 | Malaria | 8.80E-03 | 5 | P60033, O60603, P01375, P35443, P26718 | CD81, TLR2, TNF, THBS4, KLRK1 | More | | Hydrocortisone-cypionate | hsa05145 | Toxoplasmosis | 1.11E-02 | 6 | P10415, Q13489, P42224, P13765, O60603, P29965 | BCL2, BIRC3, STAT1, HLA-DOB, TLR2, CD40LG | More | | Hydrocortisone-cypionate | hsa05146 | Amoebiasis | 1.08E-07 | 12 | P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P22694, P12814, P08311 | CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSG | More | | Hydrocortisone-cypionate | hsa05152 | Tuberculosis | 7.93E-04 | 8 | Q13488, P0DP23, P42224, O60603, P10415, P13765, P01568, Q9UDY8 | TCIRG1, CALM1, STAT1, TLR2, BCL2, HLA-DOB, IFNA21, MALT1 | More | | Hydrocortisone-cypionate | hsa05163 | Human cytomegalovirus infection | 8.47E-10 | 24 | P42338, P01375, P30511, P63218, P50151, Q14643, P0DP24, Q14344, Q8NHW4, Q08828, P51828, P22694, P23458, P49841, P14778, P01584, P61073, Q13651, P25025, Q16539, Q99941, P18848, O00463, P30101 | PIK3CB, TNF, HLA-F, GNG5, GNG10, ITPR1, CALM2, GNA13, CCL4L2, ADCY1, ADCY7, PRKACB, JAK1, GSK3B, IL1R1, IL1B, CXCR4, IL10RA, CXCR2, MAPK14, CREBL1, ATF4, TRAF5, PDIA3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P60033 | CD81 | CD81 antigen | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.714 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.751 | P60033 | CD81 | CD81 antigen | P01375 | TNF | Tumor necrosis factor | -0.71 | P12429 | ANXA3 | Annexin A3 | P01375 | TNF | Tumor necrosis factor | 0.832 | P60033 | CD81 | CD81 antigen | P30511 | HLA-F | HLA class I histocompatibility antigen, alpha chain F | 0.719 | P60033 | CD81 | CD81 antigen | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.818 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.733 | P60033 | CD81 | CD81 antigen | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.884 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.875 | P12429 | ANXA3 | Annexin A3 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.75 | P01584 | IL1B | Interleukin-1 beta | P0DP24 | CALM2 | Calmodulin-2 | 0.72 | P60033 | CD81 | CD81 antigen | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | -0.774 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | P01584 | IL1B | Interleukin-1 beta | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.75 | P01584 | IL1B | Interleukin-1 beta | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.815 | P12429 | ANXA3 | Annexin A3 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | -0.754 | P01584 | IL1B | Interleukin-1 beta | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.799 | P60033 | CD81 | CD81 antigen | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.808 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.812 | P12429 | ANXA3 | Annexin A3 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.743 | P60033 | CD81 | CD81 antigen | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.76 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.936 | P12429 | ANXA3 | Annexin A3 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.749 | P01584 | IL1B | Interleukin-1 beta | P01584 | IL1B | Interleukin-1 beta | 1 | P01584 | IL1B | Interleukin-1 beta | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | 0.825 | P01584 | IL1B | Interleukin-1 beta | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.82 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | -0.769 | P12429 | ANXA3 | Annexin A3 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | -0.716 | P60033 | CD81 | CD81 antigen | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | -0.76 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.86 | P12429 | ANXA3 | Annexin A3 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.857 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.817 | P12429 | ANXA3 | Annexin A3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.805 | P01584 | IL1B | Interleukin-1 beta | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.704 | P01584 | IL1B | Interleukin-1 beta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.749 | P60033 | CD81 | CD81 antigen | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.756 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.719 | P12429 | ANXA3 | Annexin A3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.896 | P60033 | CD81 | CD81 antigen | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.708 |
| Hydrocortisone-cypionate | hsa05165 | Human papillomavirus infection | 3.10E-02 | 8 | P16144, Q05086, P01568, P42224, Q13488, Q13362, Q12778, Q13315 | ITGB4, UBE3A, IFNA21, STAT1, TCIRG1, PPP2R5C, FOXO1, ATM | More | | Hydrocortisone-cypionate | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 4.73E-02 | 6 | P01568, P42224, P62873, Q14643, P0DP23, Q9UJU2 | IFNA21, STAT1, GNB1, ITPR1, CALM1, LEF1 | More | | Hydrocortisone-cypionate | hsa05169 | Epstein-Barr virus infection | 5.97E-04 | 12 | Q13547, O00463, Q16539, P42338, P07948, P30511, P30101, Q13761, P24522, P01375, P07766, P20963 | HDAC1, TRAF5, MAPK14, PIK3CB, LYN, HLA-F, PDIA3, RUNX3, GADD45A, TNF, CD3E, CD247 | More | | Hydrocortisone-cypionate | hsa05170 | Human immunodeficiency virus 1 infection | 3.27E-04 | 18 | P42338, P30511, P62873, P63218, P50151, P0DP23, P01375, P17252, O00463, P30101, Q14643, P01568, O60603, Q13315, P07766, P20963, P10415, Q9Y6Q5 | PIK3CB, HLA-F, GNB1, GNG5, GNG10, CALM1, TNF, PRKCA, TRAF5, PDIA3, ITPR1, IFNA21, TLR2, ATM, CD3E, CD247, BCL2, AP1M2 | More | | Hydrocortisone-cypionate | hsa05200 | Pathways in cancer | 1.55E-03 | 28 | Q13751, P42338, P08238, P42224, P19174, Q9UJU2, P17252, P43246, P84022, Q13485, Q13547, P14923, P30281, P10415, Q13489, P49767, Q12778, P43657, P25116, P62873, P63218, P50151, Q14344, Q7LDG7, O75293, P0DP23, P01568, P14784 | LAMB3, PIK3CB, HSP90AB1, STAT1, PLCG1, LEF1, PRKCA, MSH2, SMAD3, SMAD4, HDAC1, JUP, CCND3, BCL2, BIRC3, VEGFC, FOXO1, P2RY5, F2R, GNB1, GNG5, GNG10, GNA13, RASGRP2, GADD45B, CALM1, IFNA21, IL2RB | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P17252 | PRKCA | Protein kinase C alpha type | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.706 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P17252 | PRKCA | Protein kinase C alpha type | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.881 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.811 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.754 | P17252 | PRKCA | Protein kinase C alpha type | P14923 | JUP | Junction plakoglobin | 0.761 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P17252 | PRKCA | Protein kinase C alpha type | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.849 | P17252 | PRKCA | Protein kinase C alpha type | P49767 | VEGFC | Vascular endothelial growth factor C | 0.719 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P17252 | PRKCA | Protein kinase C alpha type | Q12778 | FOXO1 | Forkhead box protein O1 | 0.863 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P17252 | PRKCA | Protein kinase C alpha type | P25116 | F2R | Proteinase-activated receptor 1 | 0.857 | P17252 | PRKCA | Protein kinase C alpha type | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.852 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.731 | P17252 | PRKCA | Protein kinase C alpha type | P0DP23 | CALM1 | Calmodulin-1 | -0.776 | P17252 | PRKCA | Protein kinase C alpha type | P01568 | IFNA21 | Interferon alpha-21 | 0.733 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 |
| Hydrocortisone-cypionate | hsa05202 | Transcriptional misregulation in cancer | 3.51E-02 | 12 | P14780, P27930, Q15744, Q16548, P05164, P12838, P08246, Q9C0K0, P41182, Q13547, P12980, P24522 | MMP9, IL1R2, CEBPE, BCL2A1, MPO, DEFA4, ELA2, BCL11B, BCL6, HDAC1, LYL1, GADD45A | More | | Hydrocortisone-cypionate | hsa05203 | Viral carcinogenesis | 4.62E-02 | 3 | Q12933, P42229, Q15283 | TRAF2, STAT5A, RASA2 | More | | Hydrocortisone-cypionate | hsa05204 | Chemical carcinogenesis | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Hydrocortisone-cypionate | hsa05206 | MicroRNAs in cancer | 2.97E-03 | 6 | P15311, P21860, P61978, P46531, P63279, P22105 | VIL2, ERBB3, HNRPK, NOTCH1, UBE2I, TNXB | More | | Hydrocortisone-cypionate | hsa05211 | Renal cell carcinoma | 1.06E-02 | 2 | Q06124, Q99814 | PTPN11, EPAS1 | More | | Hydrocortisone-cypionate | hsa05212 | Pancreatic cancer | 3.94E-02 | 4 | P42338, P84022, Q13485, O75293 | PIK3CB, SMAD3, SMAD4, GADD45B | More | | Hydrocortisone-cypionate | hsa05220 | Chronic myeloid leukemia | 2.16E-02 | 5 | Q13547, Q13485, P84022, P42338, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, GADD45B | More | | Hydrocortisone-cypionate | hsa05221 | Acute myeloid leukemia | 4.95E-02 | 3 | P42338, Q15744, P11215 | PIK3CB, CEBPE, ITGAM | More | | Hydrocortisone-cypionate | hsa05223 | Non-small cell lung cancer | 3.99E-02 | 4 | P17252, O43524, P19174, O75293 | PRKCA, FOXO3, PLCG1, GADD45B | More | | Hydrocortisone-cypionate | hsa05230 | Central carbon metabolism in cancer | 1.12E-02 | 1 | P11413 | G6PD | More | | Hydrocortisone-cypionate | hsa05231 | Choline metabolism in cancer | 3.99E-02 | 4 | P19174, P23743, O14494, P17252 | PLCG1, DGKA, PLPP1, PRKCA | More | | Hydrocortisone-cypionate | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 5.72E-06 | 11 | P42338, O95267, P19174, P07766, P20963, P09693, P06239, O60603, Q04759, Q16539, P01730 | PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, TLR2, PRKCQ, MAPK14, CD4 | More | | Hydrocortisone-cypionate | hsa05310 | Asthma | 1.62E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Hydrocortisone-cypionate | hsa05320 | Autoimmune thyroid disease | 1.27E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Hydrocortisone-cypionate | hsa05321 | Inflammatory bowel disease | 1.09E-03 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Hydrocortisone-cypionate | hsa05322 | Systemic lupus erythematosus | 4.18E-03 | 7 | P08246, P09871, P10747, P13765, P29965, Q6FI13, P68431 | ELA2, C1S, CD28, HLA-DOB, CD40LG, H2AC18; H2AC19, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Hydrocortisone-cypionate | hsa05323 | Rheumatoid arthritis | 1.59E-03 | 7 | Q06643, P13765, Q13488, P10747, P09341, P19875, O60603 | LTB, HLA-DOB, TCIRG1, CD28, CXCL1, CXCL2, TLR2 | More | | Hydrocortisone-cypionate | hsa05330 | Allograft rejection | 1.62E-02 | 3 | P13765, P29965, P10747 | HLA-DOB, CD40LG, CD28 | More | | Hydrocortisone-cypionate | hsa05332 | Graft-versus-host disease | 1.76E-02 | 4 | P13765, P01375, P26715, Q13241 | HLA-DOB, TNF, KLRC1, KLRD1 | More | | Hydrocortisone-cypionate | hsa05340 | Primary immunodeficiency | 4.95E-02 | 3 | P01732, P07766, P06239 | CD8A, CD3E, LCK | More | | Hydrocortisone-cypionate | hsa05415 | Diabetic cardiomyopathy | 3.66E-03 | 7 | P17252, P14598, Q15080, Q16718, O14521, P04406, P11413 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, GAPDH, G6PD | More | | Hydrocortisone-cypionate | hsa05416 | Viral myocarditis | 2.62E-02 | 3 | P13765, P29965, P10747 | HLA-DOB, CD40LG, CD28 | More | | Hydrocortisone-cypionate | hsa05418 | Fluid shear stress and atherosclerosis | 3.02E-02 | 6 | P42338, Q14145, P10599, P01375, P14778, P27930 | PIK3CB, KEAP1, TXN, TNF, IL1R1, IL1R2 | More | | |